Intraday Info: Pulmatrix Inc (NASDAQ:PULM) locked on 25/01/2017 at $1.64. It has average volume 657.69k whilst it totals volume 13,399,146. The company has EPS -1.52 and it total income 22.50 million.
Ownership Summary: Pulmatrix Inc has total institutional ownership 36.78% while its total outstanding shares 15 millions that’s value of holdings $6 million.
Active Positions: In the latest year, PULM 4 holders have raised its positions while it contains total 82,132 shares. And the strength of reduced positions holders and held positions holders are 3 and 6 respectively.
New and Sold Out Positions: In PULM force of new positions holders 1 and it has total shares 3,749. And force of sold out positions holders 3 and it has 19,043 shares.
Pulmatrix, Inc. engages in developing inhaled therapies to address extreme pulmonary illnesses the usage of its inhaled Small debris without difficulty Respirable and Emitted (iSPERSE) era. The employer proprietary product pipeline focuses on advancing remedies for uncommon illnesses, counting PUR1900, an inhaled anti-fungal for patients with cystic fibrosis, similarly to PUR1500, an inhaled product for the remedy of idiopathic pulmonary fibrosis. it’s also developing PUR0200, a branded time-honored in medical improvement for continual obstructive pulmonary ailment. The enterprise has partnershipwith Capsugel to develop inhaled therapeutics to deal with severe pulmonary sicknesses.